What one share of enVVeno Medical holds
Medical Corporation is a medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve
enVVeno Medical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$24.91 |
|---|---|
| Cash and investments | $4.22 |
| Book value | $30.71 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $17.43 | −$1,528 | $1.16 | −$595.17 | — | $152.00 |
| 2019 | $1.73 | −$423.35 | $20.20 | −$347.56 | — | $48.30 |
| 2020 | — | −$264.04 | $4.89 | −$212.95 | — | $97.75 |
| 2021 | — | −$66.65 | $1.48 | −$49.26 | — | $201.07 |
| 2022 | — | −$76.88 | $0.36 | −$49.04 | — | $143.11 |
| 2023 | — | −$66.91 | $0.09 | −$53.75 | — | $121.42 |
| 2024 | — | −$44.53 | $0.08 | −$34.44 | — | $84.15 |
| 2025 | — | −$33.06 | $0.01 | −$26.44 | — | $41.36 |
Common questions about enVVeno Medical
How much does one share of enVVeno Medical earn?
Over the last 12 months, enVVeno Medical lost $24.91 for each share.
Does enVVeno Medical pay a dividend?
enVVeno Medical didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is enVVeno Medical’s book value per share?
enVVeno Medical’s book value is $30.71 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of enVVeno Medical have?
Each share of enVVeno Medical has $4.22 of cash and investments, as of June 30, 2026.
Has enVVeno Medical bought back shares?
enVVeno Medical’s share count rose about 5405% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.